Get research updatesPublic study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study has finished and is no longer accepting participants.
In FranceLow and High Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Resistant Auditory Hallucination in Schizophrenia: a Double Blind Sham-controlled Randomised Study
This study has finished and is no longer accepting participants.
In France
Low Dose IL-2 Therapy in Patients With a Depressive Episode in the Course of a Bipolar Disorder
This study has finished and is no longer accepting participants.
In FranceA 24-Week, Flexible-Dose, Open-Label Extension Study of Lurasidone for the Treatment of Bipolar I Depression
This study has finished and is no longer accepting participants.
In FranceA Randomized, 6-Week, Double-Blind, Placebo- Controlled, Flexible-Dose, Parallel-Group Study of Lurasidone Adjunctive to Lithium or Divalproex for the Treatment of Bipolar I Depression
This study has finished and is no longer accepting participants.
In FranceResearchers compared lurasidone and placebo to find out how the approaches affected depression symptoms in people with bipolarity type I during a depressive episode.
This study has finished and is no longer accepting participants.
In FranceA Long-term, Multicenter, Open-Label, Flexible Dose Continuation Study in Subjects Who Have Completed a Prior Lurasidone Study
This study has finished and is no longer accepting participants.
In FranceResearchers compared Lurasidone and placebo, tracking side effects to assess safety in children with bipolarity type I during a depressive episode.
This study has finished and is no longer accepting participants.
In FranceThis study evaluated the safety and effectiveness of Extended-release Guanfacine Hydrochloride for people with ADHD.
This study has finished and is no longer accepting participants.
In France
This study has finished and is no longer accepting participants.
In FranceThis study has finished and is no longer accepting participants.
In FranceMazindol in Children With Attention Deficit Hyperactivity Disorder Design Study to Explore the Effectiveness, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Two Orally Administered Doses of Mazindol.
This study has finished and is no longer accepting participants.
In FranceWe gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.